Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rang in aandelen #40870
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Aandeelprijs
$0.02765
Laatst gesynchroniseerd: 2024-12-23
Marktkapitalisatie
$69.04K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Histogen Inc. (HSTO)

Categorie

Aandelsplitsingen voor Histogen Inc. (HSTO)
Het aandeel Histogen Inc. (symbool: HSTO) heeft in totaal 2 splitsingen ondergaan.
De meest recente splitsing vond plaats op Jun 03, 2022.
Eén aandeel HSTO dat vóór May 27, 2020 werd gekocht, staat nu gelijk aan 0.005 aandelen HSTO.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE